LOTUS: Protocol for a double-blind placebo controlled randomized trial of hemp-derived cannabidiol for the treatment of cannabis use disorder.
<h4>Background</h4>As cannabis legalization continues to spread across the United States, average Δ9-tetrahydrocannabinol concentrations in recreational products have significantly increased, and no prior study has evaluated effective treatments to reduce cannabis use among high potency...
Saved in:
| Main Authors: | L Cinnamon Bidwell, Renee Martin-Willett, Samantha N Melendez, Luiza Rosa, Gregory Giordano, Kent E Hutchison, Angela D Bryan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0308262 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A preliminary randomized trial of the safety, tolerability, and clinical effects of hemp-derived cannabidiol in alcohol use disorder
by: Raeghan L. Mueller, et al.
Published: (2025-04-01) -
Inflammatory state moderates response to cannabis on negative affect and sleep quality in individuals with anxiety
by: Jonathon K. Lisano, et al.
Published: (2025-07-01) -
Agronomic evaluation of hemp (Cannabis sativa L.) for cannabidiol production in Yunnan, China
by: Wenjing Ouyang, et al.
Published: (2025-05-01) -
Mode matters: exploring how modes of cannabis administration affect THC plasma concentrations and subjective effects
by: Margy Y. Chen, et al.
Published: (2025-05-01) -
Accuracy of labeled THC potency across flower and concentrate cannabis products
by: Gregory Giordano, et al.
Published: (2025-07-01)